Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MDGS
MDGS logo

MDGS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
491.88K
EV/OCF(TTM)
--
P/S(TTM)
0.68
Medigus is a Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)
Show More

Events Timeline

No data

No data

News

Newsfilter
8.5
2025-06-05Newsfilter
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq
  • Viewbix Inc. Listing: Viewbix Inc., a digital advertising technology developer, has received approval to list its shares on the Nasdaq Capital Market under the symbol "VBIX," with trading expected to commence on June 5, 2025. Xylo Technologies Ltd. holds a significant indirect stake in Viewbix through its ownership in Gix Internet.

  • Xylo Technologies Overview: Xylo Technologies is an Israeli company focused on innovative partnerships in various sectors, including advanced medical solutions, digital commerce, and electric vehicles, and it supports Viewbix's growth through its investment in Gix Internet.

Newsfilter
6.5
2024-08-15Newsfilter
Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems
  • Partnership Announcement: Xylo Technologies' affiliate, ParaZero Technologies, has partnered with a Tier 1 defense OEM to adapt its drone safety systems for military and medical missions, starting with an initial order of 50 systems for testing.

  • Future Plans: Upon successful testing, the customer intends to order hundreds more systems for a pilot program, aiming for scalable production to enhance medical delivery efficiency and safety in critical areas by the end of 2024.

-.-
2024-06-06newsfilter
Xylo: Gix Internet Signed MOU for Investment and Merger with an AI- Robotics Company
-.-
2024-05-28newsfilter
Xylo: Metagramm Successfully Completes Development of Advanced AI-Powered Writing and Grammar Product
  • New Writing Tool "Bubbl" by Metagramm:

    • Developed by Metagramm Software Ltd., Bubbl is an advanced writing tool utilizing AI, NLP, and Deep Learning for personalized text creation.
    • Offers unique capabilities for custom text tailored to the user's expression style, unlike traditional AI tools that often produce machine-like results.
    • Users can request content translation and editing into other languages, enhancing the tool's versatility.
    • Features a minimalistic design with different operating modes like interactive re-write floating window, inline, and grammar-only modes.
    • Designed to cater to various writing needs such as Business, Medical, Academic, and Blogging profiles.
  • Xylo Technologies Ltd. and Affiliations:

    • Xylo Technologies Ltd. is a tech company focused on growth partnerships in medical solutions, digital commerce, and electric vehicle markets.
    • Affiliates include Polyrizon Ltd., Gix Internet Ltd., Eventer Technologies Ltd., Charging Robotics, Inc., Revoltz Ltd., ParaZero Technologies Ltd., and Zig Miami 54 LLC.
    • Traded on Nasdaq Capital Market, Xylo aims to provide innovative technology solutions across different sectors.
  • Forward-Looking Statements:

    • The press release contains forward-looking statements regarding Xylo's expectations, risks, and uncertainties related to its current technologies and partnerships.
    • Words like "expects," "anticipates," and "intends" are used to identify forward-looking statements about future events.
    • Xylo emphasizes the potential impact of Metagramm's products on content creation, subject to risks and uncertainties discussed in SEC filings.
    • The company undertakes no obligation to revise forward-looking statements based on future events or circumstances.
    • References and links to external websites provided in the press release are for convenience, and Xylo disclaims responsibility for third-party website content.
  • Launch Plans for Bubbl:

    • Metagramm plans to launch the first version of Bubbl for selected users during the third quarter of 2024.
    • The tool aims to revolutionize document writing and rewriting processes with personalized and customized text options.
    • Different writing profiles like Business, Medical, Academic, and Blogging will have tailored assistance tools for enhanced user experience.
    • Bubbl's focus on user-specific expression styles sets it apart from conventional AI writing tools.
    • The tool's versatility extends to content translation and editing in multiple languages, adding value for diverse user needs.
-.-
2024-05-21newsfilter
Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany
-.-
2024-03-19
Medigus: Charging Robotics Announces Successful Installment of its Wireless Charging System for Automatic Car Parks
Wall Street analysts forecast MDGS stock price to rise
0 Analyst Rating
Wall Street analysts forecast MDGS stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Medigus Ltd (MDGS.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Medigus Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding MDGS

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Medigus Ltd (MDGS) stock price today?

The current price of MDGS is 0 USD — it has increased 0

What is Medigus Ltd (MDGS)'s business?

Medigus is a Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)

What is the price predicton of MDGS Stock?

Wall Street analysts forecast MDGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDGS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medigus Ltd (MDGS)'s revenue for the last quarter?

Medigus Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Medigus Ltd (MDGS)'s earnings per share (EPS) for the last quarter?

Medigus Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Medigus Ltd (MDGS). have?

Medigus Ltd (MDGS) has 77 emplpoyees as of April 03 2026.

What is Medigus Ltd (MDGS) market cap?

Today MDGS has the market capitalization of 0.00 USD.